CytoNiche
Beijing
About CytoNiche
CytoNiche focuses on the development of 3D micro-organization engineering technology. The core technology is derived from the transformation of Tsinghua University's achievements. Based on its original research technology, Huasheng Bio has launched a series of related products and services, including customized, large-scale, automated and intelligent stem cell culture. Amplification process; 3D stem cell micro-tissue regeneration treatment of new drugs and 3D cell high-throughput drug screening products.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 101 – 250
- Estimated revenue: $10K – $50K
- Total funding: $47.5M
- Funding stage: Early Stage Venture
- Last round: Series B (Sep 2025)
- Website: cytoniche.com
- Phone: +86 400-012 6688
Industries & Categories
3D Technology, Biotechnology, Health Care, Life Science
Social Profiles
Canonical: https://fsome.com/organization/cytoniche-96272 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.